Bronwen Mayo has a background in microbiology and toxicology relating to cancer treatment. She is currently a member of the Cancer Toxicities Treatment Group and is currently completing her PhD in patnership with Helsinn Healthcare looking at the effect of an naturally occuring gut peptides conventional and new cancer treatment toxicities. She has been tutoring since 2012 and has recently joined UniSA as a Lecturer in Biomedical Sciences in 2015. She also has a keen interest in promoting science in the community and has been a committee member for the Australian Society for Medical Research since 2009.
About me
Bronwen Mayo has a background in microbiology and toxicology relating to cancer treatment. She is currently a member of the Cancer Toxicities Treatment Group and is currently completing her PhD in patnership with Helsinn Healthcare looking at the effect of an naturally occuring gut peptides conventional and new cancer treatment toxicities. She has been tutoring since 2012 and has recently joined UniSA as a Lecturer in Biomedical Sciences in 2015. She also has a keen interest in promoting science in the community and has been a committee member for the Australian Society for Medical Research since 2009.
About me
Doctorate of Philosophy University of South Australia
Bachelor of Health Science (Honours) The University of Adelaide
Bachelor of Science The University of Adelaide
My current research focusses on cancer treatment-induced alimentary mucosal injury. I have recently been working on a gut peptide intervention for the alimentary side-effects of both chemotherapy and targeted therapy-induced toxicity of the gastrointestinal tract. This research includes looking into the effects of the cancer treatment and the intervention on the local mucosal environment as well as molecular alterations and changing bacterial populations (the microbiome).
Research
Excludes commercial-in-confidence projects.
The effect of GLP-2 receptor agonist, Elsiglutide, on irinotecan-induced mucositis. Univeristy of South Australia, PhD project 01/04/2012 - 30/09/2016
The effect of GLP-2 receptor agonist, Elsiglutide, on the development tyrosine kinase inhibitor-induced toxicity. Univeristy of Adelaide - Post doctoral research project 01/07/2015 - 31/10/2016
Research
Research outputs for the last seven years are shown below. Some long-standing staff members may have older outputs included. To see earlier years visit ORCID or Scopus
Open access indicates that an output is open access.
Year | Output |
---|---|
2020 |
16
15
5
|
2020 |
Open access
37
36
13
|
2019 |
117
101
9
|
2019 |
Open access
59
50
9
|
2017 |
17
15
4
|
2016 |
Open access
3
10
1
|
2015 |
Open access
26
23
|
2014 |
5
20
3
|
2013 |
Open access
9
10
|
2013 |
Open access
22
22
|
2013 |
106
102
|
2012 |
Open access
31
31
|
Bateman E, Weaver E, Klein G, Wignall A, Wozniak B, Plews E, Mayo B, White I, Keefe D, 2016, 'Serum-derived bovine immunoglobulin/protein isolate in the alleviation of chemotherapy-induced mucositis', Supportive Care in Cancer, vol. 24(1):377-85.
Bowen, J, Mayo, BJ, Plews, E, Bateman, E, Wignall, A, Stringer, AM, Boyle, F, Keefe, D, 2014, 'Determining the mechanisms of lapatinib-induced diarrhoea using a rat model', Cancer Chemotherapy and Pharmacology, vol. 74, pp. 617-627.
Pishas KI, Neuhaus SJ, Clayer MT, Schreiber AW, Lawrence DM, Perugini M, Whitfield RJ, Farshid G, Manavis J, Chryssidis S, Mayo BJ, Haycox RC, Ho K, Brown MP, D'Andrea RJ, Evdokiou A, Thomas DM, Desai J, Callen DF, Neilsen PM, 2014, 'Nutlin-3a efficacy in sarcoma predicted by transcriptomic and epigenetic profiling', Cancer Research, vol. 74(3):921-31.
Bateman E, Bowen J, Stringer A, Mayo B, Plews E, Wignall A, Greenberg N, Schiffrin E, Keefe D, 2013, 'Investigation of effect of nutritional drink on chemotherapy-induced mucosal injury and tumor growth in an established animal model', Nutrients, 2013 vol. 5(10):3948-63.
Stringer AM, Al-Dasooqi N, Bowen JM, Tan TH, Radzuan M, Logan RM, Mayo B, Keefe DM, Gibson RJ, 2013, 'Biomarkers of chemotherapy-induced diarrhoea: a clinical study of intestinal microbiome alterations, inflammation and circulating matrix metalloproteinases', Supportive Care in Cancer, vol. 21(7):1843-52.
Bowen JM, Mayo BJ, Plews E, Bateman E, Stringer AM, Boyle FM, Finnie JW, Keefe DM, 2012, 'Development of a rat model of oral small molecule receptor tyrosine kinase inhibitor-induced diarrhea', Cancer Biology and Therapy, vol. 13(13):1269-75.
Research
My current research focusses on cancer treatment-induced alimentary mucosal injury. I have recently been working on a gut peptide intervention for the alimentary side-effects of both chemotherapy and targeted therapy-induced toxicity of the gastrointestinal tract. This research includes looking into the effects of the cancer treatment and the intervention on the local mucosal environment as well as molecular alterations and changing bacterial populations (the microbiome).
External engagement & recognition
Organisation | Country |
---|---|
Al Nahdha Hospital | OMAN |
Brigham and Women's Hospital | UNITED STATES |
Entera Health Inc. | UNITED STATES |
Free University of Amsterdam | NETHERLANDS |
Ghent University | BELGIUM |
Griffith University | AUSTRALIA |
Hanson Institute | AUSTRALIA |
Helsinn Healthcare S.A. | AUSTRALIA |
Mount Sinai Hospital | UNITED STATES |
National University of Singapore | SINGAPORE |
Nestle Nutrition R & D Center | UNITED STATES |
Nestle Research centre | SWITZERLAND |
Peter MacCallum Cancer Centre | AUSTRALIA |
Radboud University Nijmegen Medical Centre | NETHERLANDS |
Royal Adelaide Hospital | AUSTRALIA |
Royal Melbourne Hospital | AUSTRALIA |
SA Pathology | AUSTRALIA |
St Vincent's Hospital Melbourne | AUSTRALIA |
Swami Rama Himalayn University | INDIA |
The Queen Elizabeth Hospital | AUSTRALIA |
University of Adelaide | AUSTRALIA |
University of Brescia | ITALY |
University of Campinas | BRAZIL |
University of Connecticut | UNITED STATES |
University of Groningen | NETHERLANDS |
University of Rochester | UNITED STATES |
University of Rochester Medical Center | UNITED STATES |
University of South Australia | AUSTRALIA |
University of Sydney | AUSTRALIA |
External engagement & recognition
Engagement/recognition | Year |
---|---|
Citations for Outstanding Contributions to Student LearningOffice for Learning and Teaching, Department of Education and Training, Australian Government |
2020 |
Member/invited speakerLt kuraCloud Brains Trust, Auckland |
2017 |
Outstanding Young Investigator of the YearMultinational Association of Supportive Care in Cancer (MASCC) |
2017 |
SA State Convenor & SponsorshipAustralian Society for Medical Research (ASMR) |
2016 |
TreasurerAustralian Society for Medical Research (ASMR) |
2016 |
Invited PresentationHelsinn Healthcare, Lugano, Switzerland |
2015 |
SA State Convenor & SponsorshipAustralian Society for Medical Research (ASMR) |
2015 |
TreasurerAustralian Society for Medical Research (ASMR) |
2015 |
TreasurerAustralian Society for Medical Research (ASMR) |
2014 |
Finalist, Best of the best basic and translational researchClinical Oncology Society of Australia |
2013 |
Invited PresentationHelsinn Healthcare Research and Development Meeting; Berlin, Germany |
2013 |
Bronwen Mayo has an interest in teaching genetics, microbiology and physiology.
Teaching & student supervision